Incontinence

Incontinence is the involuntary leakage of urine. It occurs when the sphincter, the muscle that controls urine flow from the bladder, weakens and cannot squeeze shut. Treatments for prostate cancer, including radiation therapy, radical prostatectomy and TURP (transurethral resecion of the prostate), can cause incontinence.

The most common types of incontinence in men with prostate cancer are:
  • Stress incontinence: the loss of urine while conducting activities that strain the bladder (for example, laughing, coughing or exercising).
  • Urge continence: strong, sudden urges to urinate.
Learn more about treating incontinence here:
 
     Kegel
     Exercises


Hear from some of the experts about incontinence here:
 

The Artificial Sphincter in the Management of Urinary Incontinence Following Prostate Cancer Therapy with Dr. Ron Gerridzen

September 29, 2015

During this webinar, you'll learn prostate cancer is common and often necessitates treatment which might result in detrimental effects on urinary control and sexual function, the AMS 800 artificial urinary sphincter, and its effectiveness in restoring reasonably good urinary control and quality of life for men whose urinary control has been affected by their treatment(s). This presentation will focus on the history of the device, its current format, indications for its use, pros and cons, and results.
 

Prostatectomy and Bladder Control with Marcy Dayan

September 16, 2014

During this webinar, Marcy Dayan will discuss the impact of prostatectomy (removal of the prostate) on bladder control.  By the end of this webinar you will:
• Understand how a prostatectomy can affect bladder control
• Learn what you can do to help yourself leak less
• Learn where to get help with pelvic floor exercises


 

Incontinence and Erectile Dysfunction with Dr. Sidney Radomski

May 19, 2015

This webinar explains what is urinary incontinence and erectile dysfunction. In addition to outlining the possible causes, diagnosis tests and treatment options for urinary incontinence and erectile dysfunction after prostate cancer treatment.



 

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive